Introductions; Current epidemiology of pneumoccocal disease and pneumococcal vaccine coverage in US adults; PCV20 Phase 2/3 study results in adults; PCV15 Phase 2/3 study results in adults, including adults with underlying conditions; Considerations for PCV15 and PCV 20 use in adults
This video can also be viewed at
[ Ссылка ]
![](https://i.ytimg.com/vi/pdmkLwRr5Gk/mqdefault.jpg)